 |
|
Serologic Response to Treatment of Syphilis in Patients With HIV Infection
Amos M. Yinnon, MD;
Patricia Coury-Doniger, RN, FNP;
Rita Polito, RN;
Richard C. Reichman, MD
Arch Intern Med. 1996;156(3):321-325.
Abstract
| |
Background
Much controversy exists concerning the manifestations, therapy, and response to treatment of syphilis in patients coinfected with the human immunodeficiency virus (HIV).
Objective
To assess the effect of HIV infection on the serologic response to treatment of patients with syphilis.
Methods
Sixty-four HIV-seropositive patients with syphilis were matched with 64 patients with syphilis who were HIV negative. Matching criteria included age (±5 years), sex, race, initial rapid plasma reagin (RPR) titer (±1 dilution), and stage of syphilis at entry. There were 26 matched patients with early syphilis, 26 matched patients with late syphilis, and 12 matched patients with biological false-positive RPR. The HIV-positive patients with early syphilis received three doses of penicillin G benzathine. All other patients received treatment as recommended by the Centers for Disease Control and Prevention, Atlanta, Ga. Our study's major end points were clinical and serologic response to treatment.
Results
All 16 patients with symptomatic syphilis were cured. No patient developed clinical signs of neurosyphilis during the 12-month follow-up period. Twenty-nine (56%) of 52 HIV-positive patients with early or late syphilis did not have a fourfold decrease in RPR titer 6 months after treatment compared with 20 (38%) of 52 matched controls (P=.06). No unique characteristics identifying patients who did not respond serologically could be established. The HIV-positive patients with initial RPR less than 1:32 experienced a significantly slower decrease in RPR at 12 months than did the controls (P<.001).
Conclusions
Patients with syphilis who are HIV positive are less likely to experience serologic improvement after recommended therapy than are patients with syphilis who are HIV negative. Patients with HIV infection who contract syphilis should receive intensive and prolonged follow-up, and consideration should be given to designing alternative regimens.
(Arch Intern Med. 1996;156:321-325)
Author Affiliations
From the Infectious Diseases Unit, University of Rochester Medical Center, Rochester, NY. Dr Yinnon is now with the Shaare Zedek Medical Center, Jerusalem, Israel.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Assessment of a real-time PCR test to diagnose syphilis from diverse biological samples
Gayet-Ageron et al.
Sex. Transm. Infect. 2009;85:264-269.
ABSTRACT
| FULL TEXT
Syphilis in the United States: An Update for Clinicians With an Emphasis on HIV Coinfection
Zetola et al.
Mayo Clin Proc. 2007;82:1091-1102.
ABSTRACT
| FULL TEXT
Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics
Ghanem et al.
Sex. Transm. Infect. 2007;83:97-101.
ABSTRACT
| FULL TEXT
Comparison of the serological response to treatment of early syphilis in HIV positive versus HIV negative individuals
Kingston and Higgins
Sex. Transm. Infect. 2004;80:152-153.
FULL TEXT
Syphilis in pregnancy
Genc and Ledger
Sex. Transm. Infect. 2000;76:73-79.
ABSTRACT
| FULL TEXT
Syphilis: Review with Emphasis on Clinical, Epidemiologic, and Some Biologic Features
Singh and Romanowski
Clin. Microbiol. Rev. 1999;12:187-209.
ABSTRACT
| FULL TEXT
A Randomized Trial of Enhanced Therapy for Early Syphilis in Patients with and without Human Immunodeficiency Virus Infection
Rolfs et al.
NEJM 1997;337:307-314.
ABSTRACT
| FULL TEXT
How Do HIV+ Patients with Syphilis Respond to Treatment?
Journal Watch Dermatology 1996;1996:17-17.
FULL TEXT
HOW DO HIV+ PATIENTS WITH SYPHILIS RESPOND TO TREATMENT?
JWatch General 1996;1996:7-7.
FULL TEXT
|
